How to Choose Sunscreen That Actually Protects You

There is no such thing as sunblock

The FDA does not allow sunscreen labels to promise sunblock, waterproof, or sweatproof because no product blocks all sunlight or stays on indefinitely. Sunscreen is a thin protective film with failure modes: under-application, rubbing, sweating, swimming, poor UVA coverage, visible light, product aging, and sometimes ingredient uncertainty.

That does not make sunscreen weak. It makes it a system. The useful question is not just “what SPF should I buy?” It is: what light are you trying to reduce, what skin outcome are you trying to protect, and will the product survive your actual day?

What sunscreen has actually been shown to do

Sunscreen is one of the few anti-aging consumer products with randomized human outcome evidence. In the Nambour trial, daily SPF 15+ use reduced squamous cell carcinoma tumor counts over 4.5 years compared with discretionary use. Long-term follow-up found fewer melanomas, especially invasive melanomas, although melanoma event counts were small, so I read that signal as suggestive rather than settled.

For visible skin aging, the same trial population showed 24% less measurable photoaging over 4.5 years in adults under 55. That is unusually practical evidence for something sold in a pharmacy aisle.

SPF is a burn timer, not a complete protection score

SPF mainly measures protection against erythema, or sunburn, which is driven largely by UVB. It does not directly grade UVA, visible light, water/sweat durability, real-world dose, or whether the product performs as labeled. The FDA’s broad-spectrum test uses a critical wavelength threshold, which is useful but still a pass/fail bar rather than a consumer-friendly UVA score.

This is why two SPF 50 products can behave very differently in real life. A 2022 in-vitro analysis of U.S. sunscreens found many products had much lower measured UVA protection than their SPF number would imply. I treat that study as a product-quality and labeling critique, not as proof every bottle is bad.

Visible light is the pigment gap most people miss

Ordinary visible light can worsen pigmentation, especially in darker phototypes and melasma-prone skin. Clear UV filters can be excellent against UV and still do little for visible light. That is where tint matters.

Tinted sunscreens with iron oxides physically reduce visible-light transmission. In melasma trials, UV plus visible-light protection outperformed UV-only sunscreen and helped reduce melasma relapse. Reviews of tinted sunscreens and visible-light photoprotection have continued to support this as a clinically useful lever for melasma, PIH, and pigment-prone skin.

Practical translation: if the goal is pigment control, a clear SPF 50 may be incomplete. You likely need tint, enough product, and a reapplication plan.

Mineral vs chemical sunscreen: what is proven, plausible, and not proven

The most common mistake is collapsing every concern into either “chemical sunscreen is poison” or “there is nothing to see.” The correct framing is narrower: some older organic filters are systemically absorbed; plausible endocrine/reproductive safety signals exist for some filters; human clinical harm at current sunscreen-use levels has not been established.

FDA maximal-use trials found avobenzone, oxybenzone, octocrylene, homosalate, octisalate, octinoxate, and ecamsule can reach blood levels above the FDA’s 0.5 ng/mL threshold. The 0.5 ng/mL line is a toxicology-data trigger, not a clinical harm threshold; the larger 2020 trial confirmed absorption across several common active ingredients.

For BP-3/oxybenzone specifically, a 2020 dermatology systematic review found insufficient evidence to establish causal human harm across major endocrine and reproductive endpoints. But a deeper 2023 HBM4EU review of BP-3/BP-1 argued that internal BP-3 concentrations after whole-body use may overlap with concentrations causing endocrine activity in vitro and adverse female reproductive effects in rodents, while human evidence includes mixed observational associations with menstrual hormones, fibroids, endometriosis, and other reproductive endpoints.

A 2023 ToxCast/Tox21 exposure-margin analysis found most common organic filters had low endocrine potency at measured human plasma concentrations, with oxybenzone the main filter where the exposure-to-bioactivity margin was narrower. That is why I put BP-3/oxybenzone in the highest-caution lane, not every chemical filter equally.

Homosalate is the second filter I treat cautiously: the EU Scientific Committee on Consumer Safety concluded it was not safe at 10% in its 2021 opinion and proposed much lower safe-use limits under that assessment. The same committee considered BP-3 not safe at 6% for body/spray sunscreens under its modeled conditions, while octocrylene was generally considered safe up to 10% for most uses but not at 10% in propellant spray under combined-use assumptions.

Octocrylene has a separate practical issue: contact and photocontact allergy, especially in adults with prior topical ketoprofen photoallergy, and possible product aging into benzophenone. The allergy pattern is described in photocontact allergy reviews; the degradation concern comes from work showing benzophenone accumulation from octocrylene in some commercial products over time.

Zinc oxide and titanium dioxide remain the lower-systemic-uncertainty topical default because intact-skin penetration is minimal and the FDA’s 2021 proposed order treated them as GRASE up to 25%. The caveat is form factor: sprays and powders raise inhalation concerns, and some mineral formulas underperform in independent testing. Mineral is lower uncertainty, not automatically better in every product.

Bemotrizinol is why the U.S. sunscreen conversation is changing

In June 2026, the FDA added bemotrizinol to the OTC sunscreen monograph, with the Federal Register final order allowing it up to 6%. This matters because bemotrizinol is photostable, covers UVA and UVB well, and has low skin absorption. Europe and other markets have had it for years as Tinosorb S; U.S. formulas should finally start catching up.

Vitamin D is usually not a good reason to skip sunscreen

In controlled artificial-UV experiments, sunscreen can reduce vitamin D synthesis. In real life, field studies generally show little effect on vitamin D status, likely because humans do not apply sunscreen perfectly or everywhere. A 2019 review found real-world sunscreen use has little effect on vitamin D, and a high-UV Tenerife trial found optimal sunscreen use still allowed vitamin D synthesis while preventing sunburn.

If vitamin D is clinically relevant for you, measure it and supplement if needed. Do not use sunburn as dosing.

How to choose by use case

The best sunscreen is the one that matches the setting and gets used correctly. Start with the use case, then choose the product.

• Daily city / office: broad-spectrum SPF 30+ in a texture you will wear every morning. Tinted if pigment-prone.
• Driving / window UVA: prioritize stronger UVA coverage: zinc-rich mineral, EU/Asian high-UVA systems, or upcoming bemotrizinol formulas.
• Beach / sweat / workouts: water-resistant SPF 50+, full dose, applied before exposure, then reapplied every two hours and after swimming, sweating, or toweling.
• Melasma / PIH / deeper skin tones: tinted iron-oxide sunscreen, enough product, and reapplication. Do not apply it like thin foundation and expect full protection.
• Pregnancy / kids / risk-averse default: zinc or zinc/titanium lotion plus shade, hats, UPF clothing, and avoidance of aerosols around children.
• Reef or water destinations: UPF clothing first, mineral lotion on exposed skin, and follow local bans on oxybenzone or octinoxate.